Chronic Rhinosinusitis With Nasal Polyps Clinical Trial
Official title:
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate CBP-201 in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
This study will evaluate the effect of CBP-201, rademikibart, in adult patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the effect of CBP-201 on a background of mometasone furoate nasal spray (MFNS) in reducing endoscopic nasal polyp score (NPS) and nasal congestion/obstruction score (NCS) severity in eligible patients with CRSwNP whose disease remains inadequately controlled despite daily treatment with intranasal corticosteroid (INCS) therapy in comparison to placebo. CBP-201 is administered as a subcutaneous (SC) injection. The study is divided into a treatment period of 24 weeks and a follow-up period of 8 weeks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05895929 -
The Role of IL5 in Epithelial Cell Integrity
|
Early Phase 1 | |
| Recruiting |
NCT05891483 -
Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 2 | |
| Recruiting |
NCT04998604 -
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
|
Phase 4 | |
| Recruiting |
NCT06069310 -
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
|
||
| Recruiting |
NCT05009758 -
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
|
N/A | |
| Active, not recruiting |
NCT05529784 -
Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)
|
||
| Recruiting |
NCT05902325 -
Identifying Predictors Of Response To Mepolizumab In CRSwNP
|
Phase 4 | |
| Completed |
NCT05049122 -
Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)
|
Phase 4 | |
| Not yet recruiting |
NCT05598411 -
CST1-Guided Oral Glucocorticoids Management for CRSwNP
|
Phase 4 | |
| Active, not recruiting |
NCT05553951 -
Adherence in Global Airways
|
N/A | |
| Recruiting |
NCT05131464 -
The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 2 | |
| Recruiting |
NCT05598424 -
CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
|
Phase 4 | |
| Active, not recruiting |
NCT05649813 -
A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region
|
||
| Recruiting |
NCT04628442 -
Tissue Immune Interaction in Nasal Polyposis
|
||
| Active, not recruiting |
NCT06118554 -
3D Printing to Improve Nasal Irrigation Outcome
|
N/A | |
| Active, not recruiting |
NCT04596189 -
Dupilumab for Prevention of Recurrence of CRSwNP After ESS
|
Phase 4 | |
| Recruiting |
NCT02668861 -
Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels
|
Phase 3 | |
| Active, not recruiting |
NCT05878093 -
Dupilumab in Chinese Adult Participants With CRSwNP
|
Phase 3 | |
| Not yet recruiting |
NCT06398873 -
Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP
|
||
| Completed |
NCT05931744 -
The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis
|
Phase 2/Phase 3 |